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Background: Despite recent advances in microbiological techniques, the etiology of community-acquired pneumonia
(CAP) is still not well described. We applied polymerase chain reaction (PCR) and conventional methods to describe
etiology of CAP in hospitalized adults and evaluated their respective diagnostic yields.
Methods: 267 CAP patients were enrolled consecutively over our 3-year prospective study. Conventional methods
(i.e., bacterial cultures, urinary antigen assays, serology) were combined with nasopharyngeal (NP) and oropharyngeal
(OP) swab samples analyzed by real-time quantitative PCR (qPCR) for Streptococcus pneumoniae, and by real-time PCR
for Mycoplasma pneumoniae, Chlamydophila pneumoniae, Bordetella pertussis and 12 types of respiratory viruses.
Results: Etiology was established in 167 (63%) patients with 69 (26%) patients having ≥1 copathogen. There were 75
(28%) pure bacterial and 41 (15%) pure viral infections, and 51 (19%) viral–bacterial coinfections, resulting in 126 (47%)
patients with bacterial and 92 (34%) patients with viral etiology. S. pneumoniae (30%), influenza (15%) and rhinovirus
(12%) were most commonly identified, typically with ≥1 copathogen. During winter and spring, viruses were detected
more frequently (45%, P=.01) and usually in combination with bacteria (39%). PCR improved diagnostic yield by 8% in
64 cases with complete sampling (and by 15% in all patients); 5% for detection of bacteria; 19% for viruses (P=.04); and
16% for detection of ≥1 copathogen. Etiology was established in 79% of 43 antibiotic-naive patients with complete
sampling. S. pneumoniae qPCR positive rate was significantly higher for OP swab compared to NP swab (P<.001).
Positive rates for serology were significantly higher than for real-time PCR in detecting B. pertussis (P=.001) and
influenza viruses (P<.001).
Conclusions: Etiology could be established in 4 out of 5 CAP patients with the aid of PCR, particularly in diagnosing
viral infections. S. pneumoniae and viruses were most frequently identified, usually with copathogens. Viral–bacterial
coinfections were more common than pure infections during winter and spring; a finding we consider important in
the proper management of CAP. When swabbing for qPCR detection of S. pneumoniae in adult CAP, OP appeared
superior to NP, but this finding needs further confirmation.
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Community-acquired pneumonia (CAP) is a common dis-
ease and a significant cause of morbidity and mortality
worldwide [1-3]. Differences in epidemiology of pathogens
make the knowledge of local etiology crucial for the ap-
propriate choice of empirical antimicrobial treatment,
which has a major impact on the prognosis of the pa-
tient [4-7]. An important rationale for microbial testing
is to enable pathogen-directed therapy, and thus avoid
unnecessary antibiotic use [8]. In clinical practice causative
pathogens often remain unknown, and the majority of pa-
tients are treated empirically [8]. Moreover, published data
on etiology of CAP in Norway [9], as well as in several
other countries, are hampered by old data, limited samples
and detection methods confined to bacterial culture.
The use of diagnostic methods based on polymerase
chain reaction (PCR) have resulted in increased detection
of many bacterial and viral pathogens associated with
CAP [8]. One of the advantages of PCR is its ability to
identify respiratory pathogens also after initiation of anti-
biotic therapy [10]. Some recent studies have shown
that a high microbial yield can be achieved when real-
time PCR assays are combined with conventional diag-
nostic methods like bacterial cultures, urinary antigen as-
says and serology [11-16]. Such extensive approaches have
led to recognition of viruses as important causes of CAP
and that coinfections are more common than previously
thought [17,18].
The aim of this study was to describe etiology of CAP
in adults admitted to a general hospital in South-Eastern
Norway using conventional methods and real-time PCR
assays for the detection of respiratory pathogens. We also
investigated the diagnostic yields of the methods applied,
especially the potential benefit of PCR.
Methods
Patients and study design
Adults (≥18 years old) with suspected pneumonia admit-
ted to Medical Department, Drammen Hospital, Vestre
Viken Health Trust—an acute care 270-bed general hos-
pital in the province of South-Eastern Norway serving a
mixed rural and urban population of about 160 000 in-
habitants—were consecutively evaluated for inclusion in
a prospective study from January 2008 to January 2011.
CAP was defined as (i) presence of a new pulmonary in-
filtrate on chest radiograph, (ii) rectal temperature >38.0°C,
and (iii) at least 1 of the following symptoms or signs:
cough (productive or nonproductive), dyspnea, respiratory
chest pain, crackles or reduced respiratory sounds. These
criteria had to be present within 48 h of admission. Patients
were excluded from the study when the chest radiographic
examination showed noninfectious causes such as pulmon-
ary infarction, tumor or bronchiectasis, or if the patient was
discharged from the hospital within the 2 weeks prior toadmission. All study participants were invited to an out-
patient follow-up 6 weeks after hospital discharge, including
chest radiography and a convalescent blood sample. Con-
sent was obtained at the time of recruitment. The study
was approved by the Regional Committee for Medical and
Health Research Ethics in South-Eastern Norway (reference
number: S-06266a).
Clinical data collection
Clinical data were recorded on paper case record forms
with missing data abstracted from medical records. Chest
radiographic patterns were thoroughly examined by an
independent experienced radiologist.
Microbial sample collection
Blood cultures (BD BACTEC™ Blood Culture System,
Sparks, Maryland, USA) were obtained prior to commen-
cing antibiotic therapy. Clinicians at the emergency room
or on the wards collected nasopharyngeal (NP) swab
samples—and, when possible, sputum specimens for
Loeffler stain, Gram stain (optional) and culture—also
before initiation of antibiotic therapy. In some cases,
these samples were collected at the time of recruitment
within 48 h after hospital admission. An additional NP
swab and oropharyngeal (OP) swab from posterior oro-
pharynx and both tonsillar pillars were collected for PCR
analysis on separate transport media (Copan Flocked
Swabs and UTM-RT Transport Medium System, Brescia,
Italy). Urine sample was collected for specific antigen de-
tection. Bronchoalveolar lavage (BAL) and diagnostic thor-
acentesis were performed on medical indication as judged
by the treating clinician, usually when the pneumonia did
not resolve, or—in the case of thoracentesis—the cause of
build up pleural fluid was not known. Acute-phase serum
samples were collected at the time of recruitment.
Convalescent-phase serum samples were obtained at the
time of outpatient follow-up, approximately 6 weeks after
hospital discharge.
Conventional microbiological methods
Bacteriological specimens were cultured on standard media.
BAL was cultured quantitatively in accordance with
accepted methods [19]. Growth of specific pathogens
detected in sputum and NP samples were judged semi-
quantitatively as low, intermediate or abundant. The
most purulent part of sputum samples was processed
for microscopy. Only samples displaying >25 polymorpho-
nuclear leukocytes and <10 squamous epithelial cells per
100× power field were considered acceptable for culture
[20]. For serology, commercially available assays were used
according to the manufacturer’s instructions for detection
of Mycoplasma pneumoniae, Chlamydophila pneumoniae,
Bordetella pertussis, and influenza A and B viruses (see
Additional file 1). Urinary antigen detection tests for
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serogroup 1 were performed with the BinaxNOW
pneumococcal urinary antigen test and the BinaxNOW
Legionella urinary antigen test (Binax, ME, USA).
PCR
All NP and OP samples were analyzed by real-time quan-
titative PCR (qPCR) for detection of S. pneumoniae using
primers specific for the pneumolysin (ply) gene as de-
scribed by Greiner et al. [21]; by real-time PCR for
presence of bacterial (M. pneumoniae, C. pneumoniae
and B. pertussis) and adenovirus DNA; and by real-time
reverse-transcription PCR (RT-PCR) for detection of
RNA viruses (influenza A and B viruses [reported as in-
fluenza viruses], and H1N1 on influenza A virus posi-
tive samples, parainfluenza viruses types 1–3 [reported
as parainfluenza viruses], metapneumovirus, rhinovirus,
enterovirus and respiratory syncytial virus (A and B)
[reported as respiratory syncytial virus]). Detection of S.
pneumoniae and respiratory viruses were performed retro-
spectively. Sputum samples and BAL were examined, if
medically indicated, by use of real-time PCR detection of
L. pneumophila and/or Pneumocystis jirovecii. Additional
file 1 provide details of the real-time PCR methods and
pneumococcal qPCR assay.
Complete sample collection definition
A complete sample collection constituted the collection
of blood, sputum and NP samples for culture; NP and
OP samples analyzed for S. pneumoniae, M. pneumoniae,
C. pneumoniae, B. pertussis and 12 types of respiratory
viruses by use of PCR; serological testing for M. pneumo-
niae, C. pneumoniae, B. pertussis, and influenza A and B
viruses; and urine antigen assays for detection of pneumo-
coccal and L. pneumophila antigens.
Classification of etiology
Etiology was considered to be definite if any of the fol-
lowing criteria were met: a microorganism was cultured
from blood or pleural fluid; BAL yielded growth of >105
colony-forming units per milliliter (cfu/mL) of one mi-
crobial species; urinary antigen test for S. pneumoniae or
L. pneumophila was positive; or real-time PCR detection
of L. pneumophila or P. jirovecii in sputum samples or
BAL was positive.
Etiology was considered to be probable if any of the
following criteria were met: bacteria cultured from sputum
or NP swabs (at least intermediate growth was demanded
for bacteria other than S. pneumoniae where any quantity
of growth was accepted); real-time PCR detection of M.
pneumoniae, C. pneumoniae, B. pertussis or a respiratory
virus was positive; serological diagnosis of M. pneumoniae,
C. pneumoniae or influenza viruses by CFT seroconver-
sion (i.e., <10 to ≥20 or conversely), or a 4-fold titer rise orfall, or a high CFT titer (i.e., M. pneumoniae ≥160, C.
pneumoniae ≥80, influenza A virus ≥160, influenza B
virus ≥80) of either one or both of acute- and convalescent-
phase samples, or presence of IgM antibodies ≥840 U/mL
for M. pneumoniae or ≥1.1 cut-off-index for C. pneumo-
niae; or serological diagnosis of B. pertussis by a 2-fold rise
of PT-IgG (to >30 IU/mL in convalescent-phase serum) or
fall (from >30 IU/mL in acute-phase serum), or presence of
PT-IgG ≥80 IU/mL in acute- and/or convalescent-phase
samples [22,23]. Pneumococcal DNA from NP samples
[24] corresponding to ≥105 cfu/mL [25] by use of qPCR
was also considered to be of probable significance. The
same conclusions were drawn for OP samples based on
the results from Principi et al. [26]. A case was consid-
ered coinfected if >1 pathogen, classified according to
the above-mentioned criteria, was found.
Statistical analysis
Data were analyzed using PASW statistics software, ver-
sion 20.0 (IBM SPSS, Chicago, IL). Categorical data were
summarized using frequency counts and percentages.
Continuous data were presented as mean and standard
deviation (SD). The McNemar’s test with Yates’ continuity
correction for paired proportions and the kappa statistics
were used to compare the different techniques with re-
spect to the percentage with positive results, and to evalu-
ate the degree of agreement, respectively. Methods were
selected for comparison based on level of diagnostic
significance according to the classification; i.e., only tech-
niques of which a positive result would give the same level
of significance (definite or probable) were compared. In
case of zero cells, the value of 0.5 was applied to each cell
of the table in order to be able to perform the calculations.
Kappa value <0.20 is poor, 0.21–0.40 fair, 0.41–0.60 mod-
erate, 0.61–0.80 good, and kappa value >0.81 is very good
agreement. For other category variables, groups were com-
pared by use of Pearson’s chi-square test or Fisher’s exact




Of the 320 screened patients, 267 patients were included
in the study (Figure 1). Median age was 66 years (range
19–100 years) (Table 1). The average stay in the hospital
was 6.8 days (range 1–75 days). Forty-eight (18%) patients
were admitted to intensive care unit. The overall 30-day
mortality rate was 3.7% (i.e., 10 of 267 patients died).
Microbiological etiology of CAP
A definite or probable etiology was established, by all
methods, in 167 (63%) of 267 patients, 58 (22%) of
whom diagnosis was definite. Bacterial etiology was
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Figure 1 Study flowchart. aThirty-three patients were excluded due
to no findings of new infiltrate (n = 19); chest radiograph was not
performed (n = 1); fever was not documented (n = 4); noninfectious
cause and/or bronchial obstruction (n = 7); or previous discharge
from hospital within the last 14 days (n = 2). bOf these, 43 patients
had not received antibiotics prior to hospital admission. Abbreviations:
ID, identification; CRF, case record form.
Table 1 Baseline characteristics of 267 hospitalized adult
patients with community-acquired pneumonia
Characteristics Patients
Age, years 66 (52–78)
Female/male 127 (48)/140 (52)
Nursing home resident 4 (1.5)
Patients with any comorbidity 172 (64)
Atherosclerosisa 71 (27)
COPD 60 (23)
Immune disorderb 34 (13)
Diabetes mellitus 33 (12)
Renal disease 32 (12)
Asthma 25 (9)
Congestive heart failure 22 (8)
Neurologicalc 19 (7)
Dementia 15 (6)
Active malignancy 13 (5)
Innate or acquired immunodeficiencyd 11 (4)
Liver disease 4 (1.5)
Active smoker 65 (24)
Travel historye 37 (15)
Pneumococcal vaccinef 25 (13)
Influenza vaccinef 66 (33)
Antibiotics prior to hospital admissionf 90 (36)
Immunosuppressive drugsg 37 (14)
Note: Values are presented as No. (%) or median (25th–75th percentile). COPD,
chronic obstructive pulmonary disease.
aCoronary heart disease, cerebrovascular disease and/or peripheral artery
disease.
bEleven patients with rheumatoid arthritis, 1 patient with systemic lupus
erythematosus, 6 patients with inflammatory bowel disease, 1 patient with
autoimmune hepatitis, 3 patients with Sjogren’s disease, 14 patients with
psoriasis (2 patients had 2 conditions).
cCentral nervous disease and/or neuromuscular disease.
dOne patient with antibody deficiency, 1 patient with HIV, 1 patient with heart
transplant, 2 patients with kidney transplant, 1 patient with bone marrow
transplant. Three patients had received chemotherapy and 2 had received
radiation therapy within last 3 months.
eTravel abroad past 4 weeks.
fVaccinated against pneumococcus within previous 10 years; vaccinated
against influenza virus within previous 12 months; antibiotics within previous
3 months.
gImmunosuppressive drugs were defined as any use of systemic steroids,
Azathioprine, TNF-alpha inhibitor, Cyclosporine, Cyclophosphamide and/or
Methotrexate within previous 3 months.
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(9%) had bacteremia; 21 (84%) of these cases had S. pneu-
moniae isolated of which 2 cases had additional findings
of either Haemophilus influenzae or Moraxella catarrhalis.
One case had both H. influenzae and Haemophilus parain-
fluenzae isolated from blood, and Escherichia coli, Pseudo-
monas aeruginosa and group A streptococci was isolated
from one case each. There were 7 cases of legionellosis
(3 females and 4 males; age range 41–72 years), all
caused by L. pneumophila serotype 1. Six of these patients
had a documented travel history within past 4 weeks from
a Mediterranean country (5 cases) or Asia (1 case), and 1
patient was probably infected while working on a supply-
boat in the North Sea. Viral etiology was established in
92 (34%) of 267 patients; influenza viruses were most
frequently detected followed by rhinovirus (Table 3). One
patient had Pneumocystis jirovecii detected in BAL by use
of real-time PCR.
Microbial patterns in CAP patients with an established
etiology
A total of 251 pathogens were detected in the samples
from 167 patients, the distribution patterns of the mi-
crobial agents identified in these mono- and coinfected
patients are presented in Table 4. Multiple pathogens
were detected in the samples from 69 (41%) cases; 1 add-
itional pathogen (copathogen) in 54 (32%), and 2 copatho-
gens in 15 (9%) cases. S. pneumoniae was identified in 44
(64%) of the 69 coinfected cases. Also, ≥1 copathogen was
detected in 44 (54%) of 81 episodes with S. pneumoniae.This copathogen was due to 1 additional bacterial agent in
15 (19%) of cases; and/or ≥1 viral agent in 36 (44%).
Accordingly, 36 (82%) of the 44 coinfected S. pneumoniae
episodes were attributed to ≥1 viral agent. A pure bacterial
etiology was established in 75 (45%) of the 167 patients;
and a pure viral etiology in 41 (25%). Viral–bacterial coin-
fections were established in 51 (31%) of patients; the most
common combinations were S. pneumoniae with influenza
viruses (16 of 51 patients, 31%) or rhinovirus (14 of 51,
27%) (Additional file 1: Table S1).
Table 2 Bacterial findings and contribution of different methods to diagnostic yield in the study population
Pathogen No. (%) of patients
with positive




culture (n = 14)
Urinary antigen















Streptococcus pneumoniae 81 (30) 21 - 24 - 4 10 6 16 NA
Bordetella pertussis 15 (6) NA NA NA NA NA NA - - 15
Haemophilus influenzae 14 (5) 1 - NA - 5 8 NA NA NA
Mycoplasma pneumoniae 10 (4) NA NA NA NA NA NA 7 1 2
Chlamydophila pneumoniae 7 (3) NA NA NA NA NA NA - 2 5
Legionella pneumophila 7 (3) NA NA 7 NA - NA NA NA NA
Enterobacteriaceaed 6 (2) 2 - NA - 3 1 NA NA NA
Moraxella catarrhalis 5 (2) - - NA - 2 3 NA NA NA
Miscellaneouse 3 (1) 1 1 NA - - 1 NA NA NA
Haemophilus parainfluenzae 2 (1) 1 - NA - 1 - NA NA NA
Totalf 126 (47) 26 1 31 - 15 23 13 19 22
Note: Data are number of patients, unless otherwise stated, whose infections were etiologically established by use of a particular method listed in descending order of specificity (NP vs. OP swab PCR depends on
pathogen tested). Additional patients had etiology established by use of different methods; e.g., S. pneumoniae infection was established by use of urinary antigen test in 24 additional patients whose etiology was not
established by use of blood culture etc. PCR: S. pneumoniae was detected by use of qPCR; and L. pneumophila, M. pneumoniae, C. pneumoniae and B. pertussis by use of real-time PCR. BAL, bronchoalveolar lavage; qPCR,
real-time quantitative polymerase chain reaction; NP, nasopharynx; OP, oropharynx; NA, not applicable.
aOf 165 sputum samples, 73 were of good quality. One of these tested positive for L. pneumophila by use of real-time PCR (urinary antigen test in this case was also positive).
bOf 262 patient samples, 240 revealed valid results for qPCR detection of S. pneumoniae, and 259 for real-time PCR detection of M. pneumoniae, C. pneumoniae and B. pertussis.
cOf 262 patient samples, 238 revealed valid results for qPCR detection of S. pneumoniae, and 259 for real-time PCR detection of M. pneumoniae, C. pneumoniae and B. pertussis.
dInclude either of the following: E. coli, P. aeruginosa or Enterobacter species.
eBlood culture, Group A streptococcus; Pleural fluid culture, Prevotella spp. and Dialister pneumosintes (isolated from the same patient); NP swab culture, Group A streptococcus.














Table 3 Viral findings and contribution of different methods to diagnostic yield in the study population
Pathogen No. (%) of patients
with positive
findings (n = 267)
Real-time PCR Serology
(n = 263)NP swab (n = 262)a OP swab (n = 262)b
Influenza virusesc 40 (15) 15 3 22
Rhinovirus 32 (12) 27 5 NA
Parainfluenza virusesd 8 (3) 5 3 NA
Respiratory syncytial viruse 7 (3) 7 - NA
Metapneumovirus 7 (3) 4 3 NA
Enterovirus 5 (2) 5 - NA
Adenovirus 1 (0.4) 1 - NA
Totalf 92 (34) 64 14 22
Note: Data are number of patients, unless otherwise stated, whose infections were etiologically established by use of a particular method listed in descending
order of specificity (NP vs. OP swab PCR are generally considered equally). Additional patients had etiology established by use of different methods; e.g., infection
with influenza viruses was established by use of OP swab in 3 additional patients whose etiology was not established by NP swab etc. PCR, polymerase chain
reaction; NP, nasopharynx; OP, oropharynx; NA, not applicable.
aOf 262 patient samples, 240 revealed valid results for detection of all viruses (except from influenza viruses of which 239 samples revealed valid results).
bOf 262 patient samples, 238 revealed valid results for detection of all viruses.
cInfluenza A virus (13 cases of which 2 cases were H1N1 positive), Influenza B virus (5 cases). 1 case tested positive for both influenza A and B viruses by use
of serology.
dParainfluenza virus type 1 (1 case), type 2 (2 cases), type 3 (5 cases).
eRespiratory syncytial virus A (5 cases), 2 cases were undefined.
fNo. of patients does not add up to no. of pathogens because some patients had multiple pathogens detected: a total of 100 viruses were detected in 92 patients.
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Etiology was established by conventional methods (i.e.,
bacterial cultures, urinary antigen assays and serology) in
127 (48%) of 267 cases; ≥1 bacterial agent was found in
107 (40%); and influenza viruses in 37 (14%). At least 1
copathogen was detected in 29 (11%) of cases. PCR alone
provided etiology in 102 (38%) of cases; ≥1 bacterial agent
was found in 51 (19%); ≥1 viral agent in 72 (27%); and ≥1
copathogen in 27 (10%). The total diagnostic yield im-
proved by 15% (167 vs. 127 of cases) when PCR was added
to conventional methods. Eleven different types of viruses
were detected by PCR.
The diagnostic yields obtained by the diverse methods
are shown (Figure 2A and B). The corresponding contri-
bution of each method for establishing bacterial or viral
etiology in the study population is illustrated in Table 3
and Table 4, respectively. A pairwise comparison of the
diagnostic yield obtained by each technique revealed in-
teresting findings (Additional file 1: Table S2). First, OP
swabs revealed significantly more positive results (34/235
positive, 14.5%) than NP swabs (14/235, 6.0%) for detec-
tion of S. pneumoniae by qPCR, P < .001. Secondly, for
detection of B. pertussis serology exhibited significantly
more positive results (13/256, 5.1%) than real-time PCR,
in both NP and OP swabs (both 0/256, 0.0%) P = .001.
Similar results were recorded for detection of influenza vi-
ruses by serology (34/236, 14.4%) compared to real-time
PCR in NP swabs (15/236, 6.4%) P < .001; and serology
(34/235, 14.5%) compared to real-time PCR in OP swabs
(15/235, 6.4%) P < .001. Thirdly, there was no signifi-
cant difference between sputum culture and NP swab
culture for detection of bacteria (Figure 2A). Of note,sputum samples were collected from 165 (62%) patients;
of these were only 73 (44%) deemed valid for culture by
microscopy.
Microbial yield in patients with complete sample collection
Microbial etiology was established in 47 (73%) of 64 pa-
tients with complete sample collection (Figure 3). The total
diagnostic yield improved by 8% (47 vs. 42 of 64 cases,
P = .44) when PCR was added to conventional methods;
5% (37 vs. 34) in cases with bacterial etiology; and 19%
(26 vs. 14, P = .04) in cases with viral etiology. Cases with
detection of ≥1 copathogen improved by 16% (22 vs. 12).
Of 20 (31%) patients in whom S. pneumoniae was iden-
tified, 12 (60%) had ≥1 copathogen detected. This copatho-
gen was due to ≥1 viral agent in 9 (45%) of patients.
Etiology was established in 34 (79%) of 43 patients with
complete sampling and who had not been prescribed anti-
biotics prior to hospital admission (not shown).
Seasonality
Adult CAP patients with viral findings showed marked
seasonal variations during the study period; the proportion
of cases with positive findings was significantly higher
in the winter and spring compared to summer and fall
(45% vs. 28%, P = .01) (Figure 4A). Annually outbreaks of
influenza viruses and S. pneumoniae contributed to the in-
crease of these findings during the cold half of the year
(Additional file 1: Figure S1). Only 2 cases of influenza A
(H1N1) virus infection were detected, although the H1N1
pandemic reached our region in the middle of the inclu-
sion period, May 2009. Detection rates of viral–bacterial
coinfections in patients with CAP also varied considerably
Table 4 Distribution of single and multiple bacterial and viral agents detected in 167 adults with an etiologically
established diagnosis of community-acquired pneumonia
Bacterial agents
Pure bacterial infections (n = 75) Viral–bacterial coinfections (n = 51) Total
Only one Plus other bacterium Plus virusa Plus virus and other bacterium N (%)
Streptococcus pneumoniae 37 8 29 7 81 (49)
Bordetella pertussis 2 4 4 5 15 (9)
Haemophilus influenzae 2 5 5 2 14 (8)
Mycoplasma pneumoniae 7 3 10 (6)
Chlamydophila pneumoniae 5 1 1 7 (4)
Legionella pneumophila 2 3 2 7 (4)
Enterobacteriaceae 1 3 2 6 (4)
Moraxella catarrhalis 2 1 2 5 (3)
Miscellaneousb 1 1 1 3 (2)
Haemophilus parainfluenzae 1 1 2 (1)
Subtotal cases with bacteria 60 126 (75)c
Viral agents
Pure viral infections (n = 41) Viral–bacterial coinfections (n = 51) Total
Only one Plus other virus Plus bacteriuma Plus bacterium and other virus N (%)
Influenza viruses 15d 2 21 2 40 (24)
Rhinovirus 12 2 15 3 32 (19)
Parainfluenza viruses 3 4 1 8 (5)
Respiratory syncytial virus 3 2 2 7 (4)
Metapneumovirus 3 3 1 7 (4)
Enterovirus 2 1 2 5 (3)
Adenovirus 1 1 (0.6)
Subtotal cases with viruses 39 92 (55)c
Note: Drammen, Norway, January 2008–January 2011.
aOne or two.
bGroup A streptococcus; Prevotella spp.; Dialister pneumosintes.
cPatients with multiple agents detected were counted as one individual case.
dOne patient was also coinfected with Pneumocystis jirovecii.
A B
Figure 2 Diagnostic yields of different microbiological methods. Bars are percentages of cases with a positive test relative to the number of
cases with a valid test, n (numbers inside the bars). Sputum culture: good-quality sputum by microscopy. A: Detection of bacteria and viruses,
regardless of detection spectrum. B: Detection of S. pneumoniae and influenza viruses. OP, oropharynx; NP, nasopharynx; S. pneumoniae, Streptococcus
pneumoniae; BAL, bronchoalveolar lavage; PCR, polymerase chain reaction.
Holter et al. BMC Infectious Diseases  (2015) 15:64 Page 7 of 11
Figure 3 Microbial findings in 64 cases with complete sampling
and the proportion of coinfections. S. pneumoniae, Streptococcus
pneumoniae; H. influenzae, Haemophilus influenzae; B. pertussis, Bordetella
pertussis; C. pneumoniae, Chlamydophila pneumoniae; M. pneumoniae,
Mycoplasma pneumoniae; M. catarrhalis, Moraxella catarrhalis; H.
parainfluenzae, Haemophilus parainfluenzae.
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January and February (not shown); the proportion of
viral–bacterial coinfections was significantly higher in the
winter and spring compared to summer and fall (39% vs.
10%, P = .01) (Figure 4B). During winter and spring, viral–
bacterial coinfections were more frequently detected than
either pure infection alone.
Discussion
This study is the first to describe etiology of CAP in hos-
pitalized adults in Norway using conventional methods
and PCR. The main results were: Firstly, etiology was
established in the majority of patients, especially when
samples were complete and no antibiotics were prescribedFigure 4 Seasonal variations of microbial findings in patients with CA
Each segment in the stacked bars represents the proportion of cases with a p
virus. At least one test (PCR or serology) was demanded for a valid detection
(n = 243). Continuous line shows the proportion of cases with a positive t
detection of viruses (n = 231). B: Pure bacterial, pure viral and viral–bacter
collected. RSV, Respiratory syncytial virus; CAP, community-acquired pneuprior to hospital admission. Furthermore, PCR improved
diagnostic yield, particularly in diagnosing viral infections.
Secondly, S. pneumoniae and respiratory viruses (mainly
influenza viruses and rhinovirus) were most commonly
detected, usually with copathogens. Viruses were detected
more frequently during winter and spring, which was also
the time period they occurred most commonly in com-
bination with bacteria. Thirdly, OP swabs gave more
positive results than NP swabs for qPCR detection of S.
pneumoniae; and serology gave more positive results than
real-time PCR for detection of B. pertussis and influenza
viruses.
Establishing a microbiological diagnosis for patients with
CAP is challenging. As is the case in any study of samples
not obtained through invasive techniques and with quanti-
tation, the link between presence and causal is still quite
unclear. However, in this study we applied a vast array of
available tests to determine the presence of known patho-
gens, including those only identified by real-time PCR, fol-
lowing recommendations for interpretation applicable to
our region. The diagnostic yield of 63% is consistent with
results of other studies, although reports vary considerably
from 39% to 76% [11-16,27-31]. These variations may be
attributable to differences in the epidemiology of patho-
gens, study population, diagnostic methods and available
patient specimens. The high diagnostic yield that was
achieved in the complete sampling group underscores
that etiology, nowadays, can be established in the majority
of CAP patients if multiple techniques are applied and
sample collection is optimized.
The prevalence of S. pneumoniae, other “typical” bacteria
and Legionella pneumophila, which almost exclusively
occurred in “imported” cases, are in line with previous
studies from Northern-Europe [7,11] and USA [32]. C.
pneumoniae was expectedly uncommon [7,11]. The rela-
tively high frequency of B. pertussis is probably explainedP during a 3-year period. A: Monthly distribution of viral findings.
ositive test relative to those with a valid test for detection of a specific
of influenza viruses (n = 266), whereas only PCR for all other viruses
est of any virus relative to those with a valid test for the complete
ial findings in a subset of 64 patients with complete samples
monia.
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pneumoniae due to timing; the study was conducted be-
tween two 5–7 years epidemic cycles [34].
The potential role of viruses in causing pneumonia,
both as the sole pathogen as well as in association with
bacteria, is debated. Furthermore, the validity of upper-
airway samples to establish an etiologic diagnosis is
controversial. However, the impacts of viruses per se on
adult CAP are increasingly being recognized [35-38]. In
line with other studies [11,28,29], we identified viruses
by all methods in 34% of all cases and in 41% of cases
with complete sampling. In contrast, conventional methods
identified only 14% of all cases, which confirms the in-
creased sensitivity of PCR reported by others [11,16,39].
As expected, the occurrence of adult CAP with viral find-
ings varied considerably during the year, peaking in March
at ~70%, and was significantly higher during winter and
spring compared to summer and fall. Influenza viruses
were most frequently detected; 14% by serology compared
to 6% by PCR, the difference between the two methods
being statistically significant—and no more than 2 cases
of influenza A (H1N1) virus infection were detected by
PCR—illustrating the substantial value of serology in
epidemiological studies. However, serology is generally
not recommended for clinical decision making due to
low specificity, which in our study may have led to an
overestimation of numbers since a probable diagnosis
was not only based on seroconversion but for some pa-
tients on high titer in single sample. Interestingly there
was no increase in CAP admissions due to influenza vi-
ruses during the 2009 H1N1 pandemic, indicating that
influenza viruses are major pathogens regularly occurring
in patients hospitalized with CAP irrespective of the
H1N1 pandemic. The low diagnostic yield of influenza
viruses by PCR technique also underscores the clinical
problem with false negative PCR influenza tests, and
may suggest that sampling from both the upper and lower
respiratory tract should be performed, at least in severely
affected individuals [40]. Another explanation may be that
the PCR influenza test is more likely to be negative later in
the course of a secondary pneumonia to influenza virus
infection leading to hospitalization.
Coinfections have previously been reported to account
for 4% to 30% of adult CAP [28,30]. In our study, more
than one pathogen was found in 26% of all patients and
in 34% of patients with complete sampling. In agreement
with recent studies, S. pneumoniae was the most common
bacterial agent associated with coinfections, and a copatho-
gen was found in more than one-half of the cases with the
majority of pathogens being viral agents [11,12,14,41], usu-
ally influenza viruses or rhinovirus. One of our important
observations, applying comprehensive and complete diag-
nostics, was an exceptionally high detection rate of viral–
bacterial coinfections in the course of the winter season,peaking at 60% in January and February. This number
is considerably higher than the 39% recently reported
[40], indicating that seasonal activity patterns of respira-
tory pathogens also impacts on the occurrence of adult
CAP with viral–bacterial coinfections, which appear to be
the dominant cause of pneumonia during those times.
Good-quality sputum culture is often difficult to obtain
and reported yields are varying [1]. In our study, sputum
samples were obtained from 62% of patients; of those
obtained were 56% judged as inadequate for culture, and of
those cultured revealed 21% a positive result. NP swab cul-
tures were obtained from 99% of patients; only 13% of these
revealed a positive result. Our concordance analyses indi-
cate, however, that the two methods are complementary.
PCR improved the yield by 8–15% when combined with
conventional methods, proving that PCR is a valuable tool
in addition to conventional methods. However, since
serological tests have little clinical impact in the acute
situation, our findings underscore the need for further
improvements. Our results, using flocked swabs, indi-
cate quite equal effectiveness of NP and OP sampling
for real-time PCR detection of viruses and the concord-
ance rate between the two specimens was good (~90%).
These results are in contrast to those from two previous
reports [29,42] that observed superiority of NP sampling,
one of the studies using flocked swabs [42]. To our know-
ledge, no study comparing NP and OP sampling for qPCR
detection of S. pneumoniae in adult CAP has yet been
published: In line with the findings of Principi et al. [26],
we found that OP swabs were significantly more effective
than NP swabs for qPCR detection of S. pneumoniae.
However, it is not known whether these might actually
represent false-positives as, according to our analyses,
OP swabs showed poorer specificity (90.2%) compared
to NP swabs (96.8%) (Additional file 1). Furthermore,
NP swabs were not assessed by direct fluorescent anti-
gen for specimen adequacy prior to testing. However, excel-
lent specimen adequacy of NP flocked swabs has recently
been reported [43]. Nevertheless, due to the lack of diag-
nostic gold standards, accuracy of such tests is difficult to
assess and more research is needed to confirm this finding.
Certain limitations concern data collection and analyses.
Firstly, the requirement of rectal temperature >38.0°C may
exclude predominantly elderly patients with CAP, who
remain afebrile, and hence contribute to explain the low
number of nursing home residents in the study. Secondly,
some patients who met the inclusion criteria were not en-
rolled in the study and the complete microbial sampling
could not be applied in every patient. We have, however,
no reason to suspect these factors to induce systematic
selection bias. Thirdly, not all sputum and NP culture
samples were taken before administration of antibiotics,
which influences the validity of the microbial etiology
patterns found and the comparison of diagnostic tests.
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the ply gene used, which has been identified in Strepto-
coccus mitis. However, we used quantitative technique,
and any DNA amount of S. mitis would probably have
been low, at least in NP samples. Furthermore, we did
not include a control group to determine the prevalence
of adult pneumococcal nasopharyngeal carriage. The
frequency of carriage in Norway hardly differs appre-
ciably from the 4% reported from Sweden [44]. Also,
we used a Cq cut-off value of 10
5 cfu/mL to distinguish
colonization from true infection [25]. Because we did
not include control subjects we were unable to investigate
the significance of the proportion of certain viruses, in
particular rhinovirus, among patients with CAP. Finally,
we included 48 (18%) patients with immunosuppression
(i.e., primary or acquired immunodeficiency, active malig-
nancy, immunosuppressive drugs) that may have an im-
pact on the etiological results. However, this proportion of
immunocompromized patients in our study does not ex-
ceed 25% that probably would have hampered comparison
of etiological results with other studies from which such
patients have been excluded [7]. Moreover, inclusion of
these patients may also be a strength of the study as they
better reflect the population being referred to this local
hospital. These limitations have been considered in the
analyses and presentation of results.
Conclusions
In conclusion, it was possible to establish etiology in 4
out of 5 CAP patients with the aid of PCR, which was
particularly useful in diagnosing viral infections. The main
pathogens identified were S. pneumoniae and viruses,
most often influenza viruses and rhinovirus, usually de-
tected with other agents. Viruses were more frequently
detected during winter and spring, which was also the
time period they occurred most commonly in combin-
ation with bacteria. Further research is needed to assess
whether OP is superior to NP swabbing for qPCR de-
tection of S. pneumonia in adults with CAP.
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